verified COP 2,2 · Q2 • database Scopus / SJR & Web of Science indexed

United States · Elsevier Inc.

workspace_premium Q2 — Reproductive Medicine lock Subscription

Contraception

Contraception is a journal indexed in SJR in Obstetrics and Gynecology and Reproductive Medicine with an H index of 118. It has a COP Index of 2,2 (best band Q2). It is published in English. It has a COP Index of 2,2.

Contraception focuses its scope in these topics and keywords: contraceptive, contraception, study, mifepristone, randomized, initiation, workers, abortion, compared, early, ...

ISSN: 0010-7824

Publisher: Elsevier Inc.

Category: Obstetrics and Gynecology

Indexation: verifiedScopus / SJR verifiedWeb of Science

open_in_new Portal NPD menu_book Guidelines NPD

schedule CountryOfPapers database fields

COP Index trending_up

2,2 Q2

28 of 72 journals in Reproductive Medicine

H-index · SJR 118 · 1,334

Acceptance rate pie_chart

24% Selective

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

NPD Subscription

Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

COP Index

2,2

SJR Impact

1,334

H-index

118

Docs (year)

165

Docs 3y

543

Total refs

3906

Cites 3y

1292

Citable 3y

494

Cites/Doc 2y

2.1

Ref/Doc

23.67

Immediate OA

—

Embargoed OA

NPD

Non OA / Submission

—

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Clinical and hormonal effects of ethinylestradiol combined with gestodene and desogestrel in young women with acne vulgaris

Variations of progesterone receptor and c-fos gene expression in the rat uterus after treatment with norethisterone and its A-ring reduced metabolites

Effect of desogestrel-containing oral contraceptives on vascular reactivity and catecholamine levels

Effect of 17a-ethinylestradiol, levonorgestrel, 3-keto-desogestrel, and gestodene on calcium influx via voltage-gated calcium channels in human aortic smooth muscles

Early abortifacient action of RU 486 by continuous intravenous infusion in rat

Diffusion of Nonoxynol-9 Into Human Semen In Vitro

Depot-medroxyprogesterone acetate (DMPA) and risk of invasive adenocarcinomas and adenosquamous carcinomas of the uterine cervix

Decrease in sperm number after treatment of rats with Austroplenckia populnea

Copper corrosion-simulated uterine solutions

Contraceptive status and sexual function of climacteric Chinese women

Comparative study on intermittent versus continuous use of a contraceptive pill administered by vaginal route

Clinical trial with Nestorone‚Ñ¢ subdermal contraceptive implants

SHOW MORE ARTICLES

Clinical performance of the TCu 380A and Lippes Loop IUDs in three developing countries

A 3-year double-blind, randomized, controlled study on the influence of two oral contraceptives containing either 20 ¬µg or 30 ¬µg ethinylestradiol in combination with levonorgestrel on bone mineral density

Centchroman: A new non-steroidal oral contraceptive in human milk

Cardiovascular risk factors in Norwegian women using oral contraceptives: Results from a cardiovascular health screening 1985-1988

Birth control method choice and use of barrier methods for sexually transmitted disease prevention among low-income African-American women

Anordiol produces pregnancy loss in the rat - via the embryo or via the uterus?

Analysis of contraceptive failure data in intrauterine device studies

Acceptability of medical abortion with methotrexate and misoprostol

Acceptability evaluation of a natural rubber latex, a polyurethane, and a new non-latex condom

A multicentred phase III comparative clinical trial of Mesigyna, Cyclofem and Injectable No.1 given by intramuscular injection to Chinese women

A multicentered clinical trial of the long-acting injectable contraceptive Depo Provera in Chinese women

A multicenter comparative study on the efficacy, safety, and acceptability of the contraceptive subdermal implants Norplant¬Æ and Norplant¬Æ-II

FAQs

Contraception has a COP Index of 2,2 (Q2), ranked 28 of 72 in Reproductive Medicine. SJR: 1,334.

Immediate OA APC is not available (NPD).

The acceptance rate recorded for Contraception is 24%.

Contraception

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the COP Index of Contraception?

What is the APC / publication cost?

What is the acceptance rate?